Share this article on:

Epithelial Growth of the Small Intestine in Human Infants

Thompson, Fiona M.; Catto-Smith, Anthony G.*; Moore, David†; Davidson, Geoff†; Cummins, Adrian G.

Journal of Pediatric Gastroenterology & Nutrition: May 1998 - Volume 26 - Issue 5 - pp 506-512
Original Articles

Background: Findings in studies in rodents have suggested that epithelial growth of the small intestine is dependent on activation of the immune system. The purpose of this study was to compare changes of postnatal epithelial growth with immunologic activity in humans.

Methods: Duodenal biopsies were obtained by endoscopy from 74 infants. Villus area, crypt length, and mitotic count were measured, using a microdissection technique. Enterocyte height, intraepithelial lymphocytes and mucosal mast cells were recorded in histologic sections, and soluble interleukin-2 receptor levels were measured in sera. These data were compared with those from 77 adult control subjects.

Results: Mean ± SD villus area was similar in infants compared with that in adults (0.364 ± 0.108 mm2 vs. 0.339 ± 0.1 mm2); but mean crypt length was 31% longer (270 ± 56 μm vs. 206 ± 29 μm; p < 0.0001), and mitotic count was 68% higher (4.2± 2.8 vs. 2.5 ± 1 per crypt; p < 0.0001) in infants. Enterocyte height was lower during infancy (27.0 ± 3.4 μm vs. 30.9 ± 4.6 μm; p < 0.0001). There was no evidence of a trophic effect on the small intestine of breast feeding compared with the effect of bottle feeding. Counts of intraepithelial lymphocytes but not mucosal mast cells were significantly less in infants. Mean soluble interleukin-2 receptor levels peaked during early infancy, compared with levels in adults (1,820 ± 596 U/ml vs. 695 ± 359 U/ml).

Conclusion: These results indicate that epithelial proliferation is increased during infancy at an age when immunologic activity is high.

Gastroenterology Unit, The Queen Elizabeth Hospital, Woodville South; *Department of Gastroenterology, Royal Children's Hospital, Parkville, Victoria; and †Gastroenterology Unit, Women's and Children's Hospital, North Adelaide, Australia

Received February 18, 1997; revised October 23, 1997; accepted November 3, 1997.

Address correspondence and reprint requests to Dr. F. M. Thompson, Gastroenterology Unit, The Queen Elizabeth Hospital, Woodville South, SA, 5011, Australia.

Epithelial growth and the postnatal development of the small intestine in humans remain poorly defined, mostly because of the ethical difficulties in obtaining tissue from healthy infants. Investigators studying intestinal development have therefore largely concentrated on rodents and other animals(1-8). However, there are marked differences between species in the pattern of intestinal development. Other approaches have included in vitro intestinal cell culture(9,10), explant culture of animal or human fetal intestine (11), and transplantation of intestine, either subcutaneously or underneath the kidney capsule, in rodents(12-14). There are limited studies in humans(15-17), but subject selection may have been biased toward infants with intestinal disease. Nevertheless, their results suggest that the epithelium of the small intestine in humans is more developed than that in rodents. The application of endoscopic study in infants has now allowed access to a larger population that coincidentally do not have any disease of the small intestine and yet provides a safe means of obtaining duodenal biopsy specimens for research.

Confusion exists on the timing of postnatal intestinal development in relation to breast feeding and weaning. Results of some animal studies of the trophic effect of breast milk would suggest that an accelerated phase of epithelial growth is associated with milk feeding(9,10,18-21), whereas in other animal studies, results have shown that epithelial growth occurs later during weaning, at a time when milk feeding is withdrawn(2-4). There is evidence from animal study results that mucosal T cells promote intestinal epithelial proliferation(4-8), extending the concept that if crypt proliferation is T-cell dependent in pathologic disease states, then crypt proliferation during weaning may also be T-cell dependent(7). We have shown that physiological inflammation in the small intestine in the rat peaks during weaning, with an increase in weight and cell number of mesenteric lymph nodes, with degranulation of mucosal mast cells (4), with expansion of eosinophils(5), with a peak at midweaning of interleukin-2 receptor(IL-2R) expression by T cells in the mesenteric lymph node(8), and with a peak of IL-2R expression in the lamina propria (unpublished data, Cummins, 1997). Treatment with cyclosporin A or anti-IL-2R antibody delays intestinal growth(6,8).

Most human infants are given solids between the ages of 4 and 6 months(22,23). We have previously shown that healthy human infants have elevated levels of soluble interleukin-2 receptor (sIL-2R) and γ-interferon in blood, which peak when the infant is 4 months old, in spite of low levels of IL-2R expression by blood lymphocytes(23). This is strongly suggestive of physiological inflammation during weaning in a sequestered site (e.g., mucosal tissues). Such physiological inflammation has been described in the small intestine of germ-free mice exposed to a conventional environment(24), a process that is somewhat analogous to weaning. Induction of HLA-DR expression on intestinal epithelium in humans during the first few weeks and months of life suggests physiological inflammation caused by food or bacterial antigens (25). If breast milk is trophic to the gut, then intestinal growth should occur in the first few months of life in those who are breast-fed; if the immunologic system is trophic from physiological inflammation, however, growth should occur later during and after weaning, as suggested by the results of our studies in the rat. An understanding of the factors that affect growth and maturation may give insights into how disease states occur and may help in their management(7).

Two epithelial compartments should be measured for growth studies, the intestinal villus, which is the functional unit of nutrient absorption, and the crypt, which is the proliferative unit (26). Villus area is correlated with the number of villus epithelial cells and is a better measure than villus length, because villi grow in width as well as in length(26). Intestinal crypts increase mainly in length, and so crypt length has a good correlation with the crypt cell population. Epithelial proliferation is estimated by recording mitotic figures per crypt, which is directly related to the gold standard, crypt cell production rate(26). A microdissection technique allows measurement of villus length and apical and basal widths (for calculation of villus area), crypt length, and mitotic count (26,27). Along with an increase in the number of epithelial cells, intestinal development includes maturation of individual enterocytes, which can be assessed by enterocyte height (28).

The purpose of this study was to define the characteristics of postnatal epithelial growth and development in the human small intestine. These were compared with changes in immunologic activity and feeding. Duodenal tissue was obtained from infants and young children undergoing upper gastrointestinal endoscopic examination as part of investigations for gastroesophageal reflux or for other medical indications not related to disease of the small intestine. Morphometric measurements were used for epithelial growth, mucosal mast cells (MMCs) and intraepithelial lymphocytes (IELs) were counted in the biopsy specimens, and immunologic activity was measured using sIL-2R andγ-interferon concentrations.

Back to Top | Article Outline


Infants were recruited into this study if they were undergoing endoscopy for assessment of reflux esophagitis. Consent was obtained from parents for duodenal biopsies and a blood sample to be taken during endoscopic evaluation. Full feeding histories were obtained. All endoscopic studies were performed under general anesthesia, at The Royal Children's Hospital (Melbourne) or at the Women's and Children's Hospital (Adelaide). Two duodenal biopsy specimens were taken from the second part of the duodenum, which was identified by the presence of the ampulla of Vater. Ethical approval was obtained from the human ethics committees of The Queen Elizabeth Hospital (Adelaide), The Royal Children's Hospital, and the Women's and Children's Hospital. Patients were excluded if an enteropathic condition was diagnosed (e.g., celiac disease or cow's milk allergy). Seventy-four biopsy specimens and 57 blood samples were available for the study. Specimens from the second part of the duodenum were obtained from 77 adult subjects who had endoscopic examination for reflux esophagitis, nonulcer dyspepsia, or iron deficiency at The Queen Elizabeth Hospital. Their mean age was 36 years (range, 20 to 87). Endoscopic exploration showed no macroscopic esophagitis, and evaluation of biopsy specimens and results of subsequent investigations demonstrated no pathologic condition in the upper gastrointestinal tract. Some members of this adult group have been used as control subjects in other studies(29,30).

Back to Top | Article Outline

Morphologic Assessment of the Small Intestine

Each duodenal specimen was mounted on cardboard and shaken vigorously in Clarke's fixative (75% ethanol:25% acetic acid) for 5 seconds to remove mucus and was transferred after 1 to 7 days for storage in 70% ethanol(26,27). The intestinal specimen was later stained with Feulgen's reagent and microdissected. Villus area was calculated as a trapezoid approximation, using measures of apical and basal villus widths and villus length (29). Crypt length and mitotic count per crypt were also recorded. Generally, 5 to 15 villi and crypts were measured, depending on the size of the specimen. Enterocyte height was measured in the midvillus region from the basement membrane to the brush border as the average of 3 to 10 measurements.

Back to Top | Article Outline

Measurements of Mucosal Immune Activity

Intraepithelial lymphocyte and MMC counts were used as indicators of mucosal immune activity. A second duodenal specimen was mounted on cardboard and fixed in Carnoy's fixative (60% ethanol, 30% chloroform, and 10% glacial acetic acid) before embedding in paraffin. Histologic sections were cut (5μm), and IEL and MMC numbers were recorded after staining with hematoxylin-eosin or Alcian blue (pH 0.6)/safranin. Counts were expressed per millimeter of muscularis mucosae (5).

Back to Top | Article Outline

Soluble Interleukin-2 Receptor and γ-Interferon Concentrations

sIL-2R levels were measured in sera, using an enzyme-linked immunosorbent assay (CellFree IL-2R, T Cell Sciences, Cambridge, MA, U.S.A). Sera aliquots of 25 μl were diluted 1:2 before measurement. The lower limit of detection is 50 U/ml. We have previously measured sIL-2R levels in 25 healthy adults and have recorded mean values of 695 ± 359 U/ml (23). Serum γ-interferon levels were measured using an enzyme-linked immunosorbent assay kit (Factor-Test, Inter-Test-γ, Genzyme Corporation, Cambridge, MA, U.S.A.). Sera aliquots of 50 μl were diluted 1:2 before measurement. The lower limit of sensitivity was 50 pg/ml.

Back to Top | Article Outline


Data are expressed as the mean ± SD. The 95% limits of the reference range were calculated as the mean ± 2 SD. Group mean values were compared by Student's t-test for significant differences.

Back to Top | Article Outline


Age Range and Feeding History

There were 37 infants up to 6 months, 27 infants up to 12 months and 10 infants up to 24 months of age. The overall breast-feeding rate was 75%. The median duration of breast feeding was 2 months (range, 0.06-9) in the 33 infants who had begun breast feeding. This calculation excluded those infants who were currently breast fed as well as those in whom data were not available. The median age of first introduction of solid food, generally rice cereal, was 4 months (range, 0.8-9) in 33 infants (bottle- or breast-fed) in whom data were available.

Back to Top | Article Outline

Changes in Intestinal Morphometry During Infancy

Villus area and crypt length are given in Figure 1. Mean villus area was similar in the 74 infants (0.364 ± 0.108 mm2) to that of the 77 adults (0.336 ± 0.106 mm2). Mean crypt length was increased by 31% in infants (270 ± 56 μm) compared with increases in adults (206 ± 29 μm; p < 0.0001), and mean mitotic count per crypt was increased by 68% in infants (4.2 ± 2.8) compared with increases recorded in adults (2.5 ± 1; p< 0.0001). Thus, crypt hyperplasia, measured by crypt length and mitotic count, was present during infancy but was not present in adults. It has been suggested that trophic factors in breast milk promote epithelial growth of the small intestine(1,9,10,18-21,31). To examine this proposal, intestinal morphometry was compared in those infants less than 6 months old who were still totally breast fed or who had continued bottle feeding exclusively from birth. This excluded many subjects who had been breast fed for short periods before bottle feeding or in whom weaning onto solids had been initiated. In Table 1, intestinal morphometry in subjects who were breast fed is compared with that in those who were bottle fed. There was no detectable effect of breast milk in specifically promoting intestinal growth, when defined by morphometry, but bottle feeding resulted in relative crypt hyperplasia, with increased crypt length and mitotic count per crypt.

Back to Top | Article Outline

Changes in Epithelial Cell Height During Infancy

There was no apparent change in epithelial cell height during infancy. However, mean epithelial cell height was significantly less in infants (27.0± 3.0 μm; n = 62) compared with that in adults (30.9± 4.6 μm; n = 28; p < 0.0001). This may indicate that enterocytes in infants are less mature than are those in adults and that change in enterocyte height occurs later during childhood.

Back to Top | Article Outline

Changes in Intraepithelial Lymphocyte and Mucosal Mast Cell Counts

There was no apparent change in IEL numbers during infancy. However, the mean number of IELs was significantly less in infants (30 ± 12 per mm;n = 63) compared with counts in adults (64 ± 30 per mm;n = 27; p < 0.0001). This would mean IELs expand later during childhood. The MMC count did not change during infancy, and the mean number of MMCs was similar in infants (49 ± 23 per mm; n = 63) and adults (46 ± 16 per mm; n = 21).

Back to Top | Article Outline

Soluble Interleukin-2 Receptor and γ-Interferon Concentrations During Infancy

There was a peak of sIL-2R in early infancy from 2 to 4 months of age(Fig. 2). Mean levels of sIL-2R were elevated during infancy (1,820 ± 596 U/ml; n = 57) compared with mean levels in adults (695 ± 359 U/ml; n = 25; p < 0.0001). Mean levels of γ-interferon were also elevated during infancy (150± 33 pg/ml; n = 39) compared with mean levels in adults (98± 66 pg/ml; n = 26; p = 0.0013).

Back to Top | Article Outline


The purpose of the current study was to examine postnatal epithelial growth in human small intestine. The application of endoscopic exploration in human infants has meant that a larger population is accessible for duodenal biopsies than was available in studies that relied on Crosby capsule biopsy or partially autolyzed intestinal samples obtained at autopsy(15-17). The specimens may have been biased by intestinal diseases or confounded by major illness or trauma. Endoscopic evaluation is used increasingly to assess reflux esophagitis and other medical conditions that should not confound findings in a coincidental intestinal biopsy. In this study, infants were undergoing endoscopic investigation of irritability or other indications of reflux esophagitis; and although they could not be regarded as completely healthy, their intestinal specimens showed no pathologic conditions. The indications for endoscopic evaluation were not related to any disease of the small intestine, and there was very little added risk in performing duodenal biopsies for research purposes.

Duodenal specimens from infants with reflux esophagitis had morphometric changes of crypt hyperplasia with longer crypt length and increased mitotic count, compared with changes observed in those from adult subjects. Although it might be argued that these changes could be explained by subtle pathologic condition, the same argument would also apply to specimens from adult subjects who had similar indications for endoscopic study. There was some variability of data (e.g., villus area), that is usually not present in animal studies. It is very unlikely that this represents any age-related bias of the site of the duodenal biopsy, in that most of the variance between morphometry of biopsy specimens is between subjects, rather than between different sites of the biopsy (27,32). Presumably, this relates to differences in breast or bottle feeding, the composition of feedings, whether solid supplements had been initiated, and whether there had been prolonged fasting, as well as the innate variability among human subjects when compared with variability among inbred rats. The lower epithelial height in infants compared with that in adult subjects would be compatible with immaturity of enterocytes. We have noted that enterocyte height is low and yet lactase activity is high before weaning in rats (unpublished data, Cummins, 1994). This is compatible with the lower epithelial cell height observed in infants compared with that in adults and heightened lactase activity recorded during early infancy in humans (33).

Two successive stages of development have been distinguished in human and animal studies of growth of the small intestine(1,34). Initially, there is considerable absolute and relative organ growth of the small intestine in its longitudinal axis and diameter during fetal life, in which the intestine is considered a cylindrical organ (22). In humans, the intestinal length doubles prenatally during the third trimester and then growth decelerates after birth(34). Linear growth continues during neonatal life in rodents (2-5). This growth occurs with maintenance of a relatively immature mucosa, as the epithelium grows by longitudinal binary fission of crypts (1). In humans, this stage occurs primarily in the fetus. The second stage of development, as best described in rodents, is associated with an increased proliferation of individual intestinal crypts and growth of the mucosa toward the lumen(3-5). This second phase of growth results in amplification of the intestinal surface area into more than that of a cylinder. The epithelial surface area is amplified by the circular folds(plicae circulares) in humans (these are not present in rodents), by growth of villi, and by maturation of enterocytes with increased surface area of microvilli (35). The submucosal folds and villi increase the surface area approximately fourfold in the proximal intestine, decreasing to twofold in the distal small intestine (35). The interesting finding of the current study was that villus area was similar both in infants and adults, which would indicate that villus growth had already occurred fetally or perhaps in the immediate postnatal period, and therefore any increase in intestinal surface area is related to organ growth and possibly to an increase in microvilli of individual enterocytes. Changes in microvilli were not examined, but the lower enterocyte height in infants compared with that in adults in this study might indicate that enterocyte maturation will develop later in childhood and will include development of microvilli, which are known to amplify the epithelial surface area another 15-fold (36). Mucosal growth is associated with maturation of digestive functions to an adult pattern (5). Monosaccharide absorption, measured by the xylose test, also increases during the postnatal period, confirming an increase in intestinal surface area(36).

A variety of trophic factors have been suggested to control epithelial growth in the small intestine, including induction from the mesenchyme, genetic preprogramming, drive from luminal factors, and endocrine effects of systemic or local hormones(1,37-46). It still remains unclear which of these factors are physiologically relevant. A popular notion has been that breast milk has a specific trophic effect on the small intestine. We showed that breast feeding was not associated with increased epithelial growth. This agrees with results in other studies in rodents, in which it has been known for some time that the accelerated period of postnatal mucosal growth occurs during weaning and not during milk feeding(3-5). It has also been known for some time that artificial feeding of rat pups leads to precocious growth of the small intestine, rather than to delayed intestinal growth, as might be expected if no breast milk was given (47-49).

Results of our previous studies in rats have suggested that mucosal T cells also promote intestinal growth (6-8). We have shown that mucosal immunologic activity peaks at midweaning in the rat, and that inhibition with either cyclosporin A (6) or with anti-IL-2R antibody inhibits epithelial growth (8). We also showed in healthy infants that sIL-2R levels (indicating total T-cell activity) peak at midweaning (4 months); but these did not originate from systemic lymphocytes, suggesting that the activated lymphocytes reside in a sequestered site, the largest of which is in the gastrointestinal tract(23). Taken together, these results in rodent and human studies satisfy two important criteria for assigning a physiological role for any trophic factor that may promote intestinal growth(22): first, that the physiological activity of the trophic factor should be increased at the time of intestinal growth, and second that physiological blockade of the trophic factor reduces intestinal growth. A third criterion is also satisfied, in that supraphysiological stimulation by the trophic factor induces precocious growth, as is seen in neonatal graft-versus-host reaction in mice in which heightened immune activity initially induces precocious intestinal maturation before evolving into an enteropathic condition with unrestrained immunologic activity(50). Recent findings in studies suggest that there may be a three-way interaction between mucosal T cells, growth factors from pericryptal fibroblasts, and proliferation of intestinal crypts(44,45,51).

In the current study, we used sIL-2R and γ-interferon levels and IEL count as indicators of immune activity and compared these with adult levels. We showed that sIL-2R levels were high during infancy before 6 months of age, similar to findings in our previous human study that showed sIL-2R levels peak at 4 months of age (midweaning) in healthy infants (23). A similar peak of sIL-2R levels during early infancy was recorded by Chan et al. from infants undergoing endoscopic study (52).γ-Interferon levels in blood were also elevated during infancy compared with levels in adults. Further evidence for immunologic activity in the intestine is the induction of HLA-DR expression on intestinal epithelium during the first few weeks and months of life in humans(25), presumably because of local γ-interferon production that also increases systemic levels, as we observed. Expansion of IELs is also a marker of immune activation (53), although it lags behind other markers-for example, IL-2R expression of mesenteric lymph node cells or mucosal mast cell degranulation in rats (5). In the current human study, the finding of a lower IEL count during infancy and a higher IEL count in adults would indicate a similar lag in expansion of IELs, presumably during early childhood. Such postnatal expansion of IELs during childhood has been shown in results of a study using a combination of intestinal samples from autopsies, aspiration biopsies, and surgical resection specimens (54). We have postulated that this intense immunologic activity is related to exposure of the mucosa-associated immune system to food and bacterial and environmental antigens, as well as to withdrawal of the immunosuppressive effect of breast milk(8,23)

We conclude that postnatal maturation of the small intestine of human infants occurs with increased epithelial crypt proliferation and maturation of enterocytes. Although these changes were lower in magnitude than those observed in rodents, they were nevertheless significant. We found no evidence that breast milk is a specific trophic factor. In addition, we confirmed that infancy in humans is associated with heightened immunologic activity that would be compatible with this activity's acting as a trophic factor for the human small intestine (8,23).

Acknowledgment: The authors thank Drs. D. Cameron, R. Couper, and T. Pouras for allowing us to study infants under their care, and J. Ripper and D. Wright for their assistance in collecting and transporting samples.

Back to Top | Article Outline


1. Klein RC, MacKenzie JC. The role of cell renewal in the ontogeny of the intestine. II. Regulation of cell proliferation in adult, fetal and neonatal intestine. J Pediatr Gastroenterol Nutr 1983;2:204-28.
2. Hruby L. A quantitative study of the relative growth of the small intestine of the rat during the period of suckling. Folia Morphol (Praha) 1966;14:308-14.
3. Herbst JJ, Sunshine P. Postnatal development of the small intestine of the rat. Changes in mucosal morphology at weaning. Pediatr Res 1969;3:27-33.
4. Cummins AG, Munro GH, Miller HRP, Ferguson A. Association of maturation of the small intestine at weaning with mucosal mast cell activation in the rat. Immunol Cell Biol 1988;66:417-22.
5. Cummins AG, Steele TW, LaBrooy JT, Shearman DJC. Maturation of the rat small intestine at weaning: Changes in epithelial cell kinetics, bacterial flora and mucosal immune activity. Gut 1988; 29:1672-1679.
6. Cummins AG, LaBrooy JT, Shearman DJC. Effect of cyclosporin A in delaying maturation of the small intestine during weaning in the rat. Clin Exp Immunol 1989;75:451-6.
7. Marsh MN, Cummins AG. The interactive role of mucosal T lymphocytes in intestinal growth, development and enteropathy. J Gastroenterol Hepatol 1993;8:270-8.
8. Thompson FM, Mayrhofer G, Cummins AG. Dependence of epithelial growth of the small intestine on T cell activation during weaning in the rat. Gastroenterology 1996;111:37-44.
9. Heird WC, Schwarz SM, Hansen IH. Colostrum-induced enteric mucosal growth in beagle puppies. Pediatr Res 1984;18:512-5.
10. Read LC. Milk-derived epidermal growth factor (EGF): Is it important to the suckling infant? Breastfeeding Rev 1989;13:33-4.
11. Arsenault P, Menard D. Influence of hydrocortisone on human fetal small intestine in organ culture. J Pediatr Gastroenterol Nutr 1985;4:893-901.
12. Leapman SB, Deutsch AA, Grand RJ, Folkman J. Transplantation of fetal intestine: Survival and function in a subcutaneous location in adult animals. Ann Surg 1974;179:109-14.
13. Winter HS, Hendren RB, Fox CH, et al. Human intestine matures as nude mouse xenograft. Gastroenterology 1991;100:89-98.
14. Ferguson A, Gerskowitch VP, Russell RI. Pre- and post-weaning disaccharidase patterns in isografts of fetal mouse intestine.Gastroenterology 1973;64:292-7.
15. Walker-Smith JA. Variation of small intestinal morphology with age. Arch Dis Child 1972;47:80-3.
16. Penna FJ, Hill ID, Kinston D, Robertson K, Slain G, Shiner M. Jejunal mucosal morphometry in children with and without gut symptoms and in normal adults. J Clin Pathol 1981;34:386-92.
17. Risdon RA, Keeling JW. Quantitation of the histological changes found in small intestinal biopsy specimens from children with suspected coeliac disease. Gut 1974;15:9-18.
18. Berseth CL. Enhancement of intestinal growth in neonatal rats by epidermal growth factor in milk. Am J Physiol 1987;253:G662-5.
19. Koldovsky O. Search for role of milk-borne biologically active peptides for the suckling. J Nutr 1989;119:1543-51.
20. Corps AN, Brown KD. Stimulation of intestinal cell proliferation in culture by growth factors in human and ruminant mammary secretions. J Endocrinol 1987;113:285-90.
21. Zumkeller W. Relationship between insulin-like growth factor-1 and -II and IGF-binding proteins in milk and gastrointestinal tract: Growth and development of the gut. J Pediatr Gastroenterol Nutr 1992;15:357-369.
22. Henning SJ, Rubin DC, Shulman RJ. Ontogeny of the intestinal mucosa. In: Johnson LR, ed. Physiology of the gastrointestinal tract. New York: Raven Press, 1994:571-610.
23. Cummins AG, Eglinton BA, Gonsalez A, Roberton DM. Immune activation during infancy in healthy humans. J Clin Immunol 1994; 14:107-15.
24. Sprinz H. Morphological response of intestinal mucosa to enteric bacteria and its implication for sprue and Asiatic cholera.Federation Proceedings 1962;21:57-64.
25. Rognum TO, Thrane PS, Stoltenberg L, Vege A, Brandtzaeg P. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res 1992;32:145-9.
26. Goodlad RA, Levi S, Lee CY, Mandir N, Hodgson H, Wright NA. Morphometry and cell proliferation in endoscopic biopsies: Evaluation of a technique. Gastroenterology 1991;101:1235-41.
27. Hasan M, Ferguson A. Measurements of intestinal villi in non-specific and ulcer-associated duodenitis between area of microdissected villus and villus epithelial cell number. J Clin Pathol 1981; 34:1181-6.
28. Howdle PD, Corazza GR, Bullen AW, Losowsky MS. Gluten sensitivity of small intestinal mucosa in vitro: Quantitative assessment of histologic change. Gut 1981;80:442-50.
29. Cummins AG, LaBrooy JT, Stanley DP, Rowland DP, Shearman DJC. Quantitative histological study of enteropathy associated with HIV infection. Gut 1990;31:317-21.
30. Cummins AG, Penttila IA, LaBrooy JT, Robb TA, Davidson GP. Recovery of the small intestine in coeliac disease on a gluten-free diet: Changes in intestinal permeability, small bowel morphology and T-cell activity. J Gastroenterol Hepatol 1991;6:53-7.
31. Weaver LT. Milk and the neonatal gut: Comparative lessons to be learnt. Equine Vet J 1986;18:427-9.
32. Gupta M, Mayhew TM, Bedi KS, Sharma AK, White FH. Inter-animal variation and its influence on the overall precision of morphometric estimates based on nested sampling designs. J Microsc 1983;131:147-54.
33. Grand RJ, Watkins JB, Torti FM. Development of the human gastrointestinal tract (review). Gastroenterology 1976;70:790-810.
34. Weaver LT, Austin S, Cole TJ. Small intestinal length: A factor essential for gut adaptation. Gut 1991;32:1321-3.
35. Wilson JP. Surface area of the small intestine in man.Gut 1967; 8:618-21.
36. Ducker DA, Hughes CA, Warren I, McNeish AS. NeonatalGut function, measured by the one hour blood D (+) xylose test: Influence of gestational age. Gut 1980;21:133-6.
37. Kedinger M, Simon-Assmann PM, Lacroix B, Marxer A, Hauri HP, Haffen K. Fetal gut mesenchyme induces differentiation of cultured intestinal endodermal and crypt cells. Dev Biol 1986;113: 474-83.
38. Haffen K, Kedinger M, Simon-Assman P. Mesenchyme-dependent differentiation of epithelial progenitor cells in the gut. J Pediatr Gastroenterol Nutr 1987;6:14-23.
39. Reicken EO, Stallmach A, Zeitz M, Schulzke JD, Menge H, Gregor M. Growth and transformation of the small intestine-importance of connective tissue, gut-associated lymphoid tissue and gastrointestinal regulatory peptides. Gut 1989;30:1630-40.
40. Ulshen MH, Dowling RH, Fuller CR, Zimmermann EM, Lund PK. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Gastroenterology 1993;104:973-80.
41. Buts J-P, De Keyser N, Dive C. Intestinal development in the suckling rat: Effect of insulin on the maturation of villus and crypt cell functions. Eur J Clin Invest 1988;18:391-8.
42. Podolsky DK. Regulation of intestinal epithelial proliferation: a few answers, many questions. Am J Physiol 1993;264:G179-86.
43. Housely RM, Morris CF, Boyle W, et al. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 1994;94: 1764-77.
44. Dignass AU, Lynch-Devaney K, Podolsky DK. Hepatocyte growth factor/scatter factor modulates intestinal epithelial proliferation and migration. Biochem Biophys Res Commun 1994;202: 701-9.
45. Liu L, Russell SM, Nicoll CS. Analysis of the role of basic fibroblast growth factor in growth and differentiation of transplanted fetal rat paws and intestines. Endocrinology 1990;126:1764-70.
46. Dignass AU, Tsunekawa S, Podolsky DK. Fibroblast growth factors modulate intestinal epithelial cell growth and migration.Gastroenterology 1994;106:1254-62.
47. Messer M, Thomas EB, Terrasa AG, Dallman PR. Artificial feeding of infant rats by continuous gastric infusion. J Nutr 1969;98: 404-10.
48. Yeh KY. Small intestine of artifically reared rat pups: Weight gain and changes in alkaline phosphatase, lactase, sucrase activities during development. J Nutr 1981;113:1489-95.
49. Kanno T, Koyanagi N, Katoku Y, et al. Simplified preparation of a refined milk formula comparable to rat's milk: influence of the formula on development of the gut and brain in artifically reared rat pups. J Pediatr Gastroenterol Nutr 1997;24:242-52.
50. Lund EK, Bruce MG, Smith MW, Ferguson A. Selective effects of graft-versus-host reaction on disaccharidase expression by mouse enterocytes. Clin Sci 1986;71:189-98.
51. Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M. T lymphocytes synthesize and export heparin-binding epidermal factor-like growth and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: Differential production and release by CD4+ and CD8+ T-cells. Proc Natl Acad Sci USA 1994;91:2890-4.
52. Chan KN, Phillips AD, Walker-Smith JA, MacDonald TT. Serum interleukin-2 receptor in infants and young children. Acta Paediatr 1995;84:151-5.
53. Mowat AMI, Ferguson A. Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine. Gastroenterology 1982;83:417-23.
54. Machado CS, Rodrigues MA, Maffei HV. Gut intraepithelial lymphocyte counts in neonates, infants and children. Acta Paediatr 1994;83:1264-67.

Cited By:

This article has been cited 2 time(s).

Journal of Pediatric Gastroenterology and Nutrition
Activation of the Gut-Associated Lymphoid Tissue With Expression of Interleukin-2 Receptors That Peaks During Weaning in the Rat
Masjedi, M; Tivey, DR; Thompson, FM; Cummins, AG
Journal of Pediatric Gastroenterology and Nutrition, 29(5): 556-562.

Journal of Pediatric Gastroenterology and Nutrition
Crypt Fission Peaks Early During Infancy and Crypt Hyperplasia Broadly Peaks During Infancy and Childhood in the Small Intestine of Humans
Cummins, AG; Catto-Smith, AG; Cameron, DJ; Couper, RT; Davidson, GP; Day, AS; Hammond, PD; Moore, DJ; Thompson, FM
Journal of Pediatric Gastroenterology and Nutrition, 47(2): 153-157.
PDF (210) | CrossRef
Back to Top | Article Outline

Epithelial growth; Mucosal immune system; Small intestine

© Lippincott-Raven Publishers